Credo Diagnostics Biomedical Pte. Ltd.
Founded with” Advanced Medical Technology for All” as its mission, Credo Diagnostics has successfully deployed the molecular diagnostic platform, VitaPCR™ machine, in over 50 countries worldwide. It enables the swift detection of infectious diseases in just 20 minutes with only 1-minute hands-on preparation. In 2022, Credo Diagnostics introduced VitaDataLink connectivity software for data management which allows automatic transfer of HL7 messages across disparate healthcare systems.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
NoProducts to be exported:
VitaPCR™ instrument, VitaPCR™ SARS-CoV-2 Gen 2 Assay, VitaPCR™ Flu A&B Assay, VitaPCR™ Flu / SC2 Assay, VitaPCR™ Flu / RSV Assay, VitaPCR™ Strep A Assay, and other respiratory panels.Business Needs:
Distributor/Agent/Representative